Wednesday , July 30th , 2025  

Emaar The Economic City & Al Tahaluf Sign Deal to Deliver New Residential Projects in KAEC’s Al Murooj

KING ABDULLAH ECONOMIC CITY (KAEC), Saudia Arabia, July 30, 2025 (GLOBE NEWSWIRE) — Emaar, The Economic City (EEC), the master developer of King Abdullah Economic City (KAEC), has signed an agreement with Al Tahaluf, a Saudi–American joint venture comprised of a K. Hovnanian subsidiary and the Hamad bin Saedan Real Estate Company, to develop two premium residential communities in the...

DebitMyData Closes Oversubscribed Seed Round- Launches $1B Human Energy Grid Global Expansion

DebitMyData™ Logo FORT LAUDERDALE, Fla., July 30, 2025 (GLOBE NEWSWIRE) — DebitMyData™, Inc.—the powerhouse has closed a seed round at more than twice its original target. This surge of investor confidence paves the way for a bold, billion–dollar global rollout of DebitMyData™’s Human Energy Grid, setting a new standard for individual data ownership, ethical...

Dr. Falk Pharma und Allianthera (Suzhou) Biopharmaceuticals gehen strategische Partnerschaft für die Entwicklung eines neuartigen AhR-Agonisten ein

Freiburg (Deutschland), Suzhou (China) und Boston (USA), 30. Juli 2025:  Dr. Falk Pharma GmbH und Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. geben strategische Partnerschaft für die Entwicklung eines neuartigen AhR–Agonisten zur Behandlung mittelschwerer bis schwerer Colitis ulcerosa bekannt. Dr. Falk Pharma GmbH, ein forschungsbasiertes Pharmaunternehmen und Spezialist für...

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025:  Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis  Dr. Falk Pharma GmbH, a research–based pharmaceutical company specializing in digestive and metabolic medicine, Allianthera...

A Launchpool da Bitget apresenta GAIA com mais de 4,7 milhões de tokens em recompensas

VICTORIA, Seicheles, July 30, 2025 (GLOBE NEWSWIRE) — A Bitget, a corretora de criptomoedas líder e empresa de Web3, anunciou a apresentação da Gaia (GAIA) na sua launchpool, bem como um registo para negociação à vista. Gaia é uma infraestrutura de computação descentralizada que permite a todos criarem, implementarem, escalarem...

Bitget Launchpool intègre GAIA à raison de plus de 4,7 millions de jetons-récompenses à la clé

VICTORIA, Seychelles, 30 juill. 2025 (GLOBE NEWSWIRE) — Bitget, première bourse de cryptomonnaies et société Web3, annonce l’intégration de Gaia (GAIA) sur son Launchpool et sa cotation sur sa plateforme de trading au comptant. Gaia est un réseau décentralisé permettant à chacun de créer, déployer, faire évoluer...

Ambiq Announces Pricing of Upsized Initial Public Offering

AUSTIN, Texas, July 29, 2025 (GLOBE NEWSWIRE) — Ambiq Micro, Inc. (“Ambiq”), a technology leader in ultra–low–power semiconductor solutions for edge AI, today announced the pricing of its upsized initial public offering of 4,000,000 shares of its common stock at a public offering price of $24.00 per share. The gross proceeds to Ambiq from the offering, before deducting...

Information on the total number of voting rights and shares

REGULATED INFORMATION Information on the total number of voting rights and shares Mont–Saint–Guibert (Belgium), July 29, 2025, 10:45 pm CET / 4:45 pm ET – In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of...

Informations sur le nombre total de droits de vote et d'actions

INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont–Saint–Guibert (Belgique), le 29 juillet 2025, 22:45h CET / 16:45h ET – Conformément à l'article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH)...

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 Mont–Saint–Guibert, Belgium – Tuesday July 29, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that...